Anivive develops AI-driven diagnostic and therapeutic solutions for veterinary oncology, utilizing next-generation tumor genotyping and advanced imaging techniques to enhance precision in cancer treatment for pets. The company addresses the urgent need for effective therapies and vaccines against diseases like Valley Fever and FIP, improving health outcomes for animals in critical conditions.
Funding
$45M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Veterinary oncology faces challenges in accurately diagnosing and treating cancer in pets due to limited access to advanced diagnostic tools and personalized treatment plans. Common diseases like Valley Fever and FIP lack effective preventative measures and therapies, leading to poor health outcomes for affected animals.
Solution
Anivive develops AI-driven diagnostic and therapeutic solutions to improve pet health, particularly in oncology and infectious diseases. The company's Searchlight DNA service offers next-generation tumor genotyping to enable personalized cancer treatment plans. Anivive is also developing vaccines and therapies for diseases like Valley Fever and FIP, addressing critical unmet needs in veterinary medicine. Their approach combines advanced research, AI-powered data analysis, and targeted drug development to provide more effective and affordable treatments for pets.
Target Audience
The primary target audience includes veterinary professionals, pet owners, and clinical researchers focused on improving the diagnosis, treatment, and prevention of diseases in pets.
Features
- Searchlight DNA: Next-generation tumor genotyping for personalized cancer treatment plans.
- AI Imaging: Deep convolutional neural networks for detecting systemic fungal infections in dogs.
- Central marketplace connecting pets with clinical studies based on their medical needs.
- All-in-one platform to manage clinical studies, speeding up the enrollment process.
- Development of a Valley Fever vaccine for canines (CPS1USDA).
- Development of a FIP treatment for felines (INADI-013287).
- AI-powered research engine populated with decades of global research and over 1 billion datapoints.